Future Growth
Future criteria checks 0/6
Vicarious Surgical's earnings are forecast to decline at 0.3% per annum while its annual revenue is expected to grow at 58.5% per year. EPS is expected to grow by 5.4% per annum. Return on equity is forecast to be -155.9% in 3 years.
Key information
0%
Earnings growth rate
n/a
EPS growth rate
| earnings growth | 0% |
| Revenue growth rate | 0% |
| Future return on equity | 0% |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RBOT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: RBOT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: RBOT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: RBOT is forecast to have no revenue next year.
High Growth Revenue: RBOT is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RBOT is forecast to be unprofitable in 3 years.
Discover growth companies
Price
7D
1Y
Mkt cap
PS
E.Growth
Analysts Target
Price
7D
1Y
Mkt cap
PS
E.Growth
Analysts Target
Price
7D
1Y
Mkt cap
PS
E.Growth
Analysts Target
Price
7D
1Y
Mkt cap
PS
E.Growth
Analysts Target